Current treatments for Graves’ hyperthyroidism (GH) and Graves’ orbitopathy (GO) are ineffective. Researchers assessed the preclinical in vitro efficacy of SYD-5115 (Byondis BV), a novel low-molecular-weight thyrotropin receptor (TSH-R) antagonist. The compound comprises ...
(NewMediaWire) - May 15, 2023 - DALLAS —“Upstream” causes of health inequities related to stroke, such as structural racism and structural conditions of the places where people live, learn, work and play, have not been studied well, according to a new American Heart ...
Illustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al. A protein found abundantly in breast cancers that are refractory to conventional treatments is thought to cause the development of metastasis. ...
While there are treatments that can help reduce the number and severity of MS attacks, many people with MS eventually develop a more severe form of the disease calledsecondary progressive MS. Unfortunately, there are few treatments for secondary progressive MS. And there are no drugs approved for...
Figure 1. Recent AFiBgCurGe 21. RinecheinbtiAtoBrCs:G2Kinoh1i4b3itor(sI:)K; os1m43a(lIl); smmoalllemcuolecsulebsabsaesded onn 1,14,64-,s6u-bssutbitustietduqteudinazo- quinazoline scaffoldlin(eIsIc)a, ff2o,l4d-(dIIis),u2b,4s-tdiitsuutbesdtitupteydripdyoripdyorpiymrimidiid...
The lead investigator, Professor Russell Gruen, now Dean of the College of Health and Medicine at the Australian National University, described this as a landmark study in trauma care. "It shows it's not enough to find out only whether treatments save lives or not—quality of life and the...